By JUDY SIEGEL-ITZKOVICH
An H1N1 flu patient who has completely recovered was identified at the Health Ministry's central virus lab as having a strain resistant to treatment by Tamiflu, the antiviral drug that is being prescribed to high-risk H1N1 patients.
The same has happened in other countries around the world.
The ministry said Thursday that it was continuing to study the resistant strain and its significance, but was not changing its policy on dealing with the H1N1 flu.
US says Yemen's Houthis targeted bulk carrier bound for port of Aden